Publications by authors named "Anhui Shi"

Claim this Profile
I
Incorporating intra-fractional delta-radiomics from 4DCT improves local recurrence prediction.
Qijian Lu, Jiayi Yu, Yasi Zhang, Xinhui Fu, Tian Li, Anhui Shi

Med Phys· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction immunochemotherapy followed by definitive chemoradiotherapy and consolidation immunotherapy for unresectable stage III non-small cell lung cancer: a multi-institutional retrospective cohort study.
Zhixue Fu, Xin Dong, Jiawen Sun, Wei Deng, Yuting Zhao, Anhui Shi

Front Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes of thoracic radiotherapy in addition to first-line immunotherapy in metastatic non-small cell lung cancer: a multicenter, propensity score-matched analysis.
Zhe Du, Yuting Zhao, Lehui Du, Anhui Shi, Huiming Yu

J Thorac Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy concurrently administered with chemoradiotherapy in limited-stage small-cell lung cancer.
Liuhua Long, Leilei Jiang, Yue Teng, Dan Yang, Xin Dong, Anhui Shi

BMC Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to escalate quality assurance in small-cell lung cancer radiotherapy trials - Authors' reply.
Jiayi Yu, Jun Zhao, Anhui Shi

Lancet Respir Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric comparison of IMPT vs VMAT for multiple lung lesions: an NTCP model-based decision-making strategy.
Yang Liu, Peilin Liu, Xian-Shu Gao, Zishen Wang, Feng Lyu, Anhui Shi

Med Dosim· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial.
Jiayi Yu, Leilei Jiang, Lina Zhao, Xue Yang, Xiaomin Wang, Anhui Shi

Lancet Respir Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.
Ying Cheng, David R Spigel, Byoung Chul Cho, Konstantin K Laktionov, Jian Fang, Yoshitaka Zenke, Yoshimasa Shiraishi, Anhui Shi

N Engl J Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-assisted delineation for postoperative radiotherapy in patients with lung cancer: a prospective, multi-center, cohort study.
Ziming Han, Yu Wang, Wenqing Wang, Tao Zhang, Jianyang Wang, Anhui Shi

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis.
Jingwei Zhang, Jiayi Yu, Dan Yang, Leilei Jiang, Xin Dong, Anhui Shi

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anlotinib hydrochloride consolidation after concurrent chemoradiotherapy in stage III non-small-cell lung cancer: a truncated, randomized, multicenter, clinical study (ALTER-L029).
Dan Yang, Xiaomin Li, Xiaoying Xue, Leilei Jiang, Anhui Shi

Anticancer Drugs· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical association between plan complexity and the local-recurrence-free-survival of non-small-cell lung cancer patients receiving stereotactic body radiation therapy.
Chenguang Li, Shutong Yu, Junyue Shen, Baosheng Liang, Xinhui Fu, Anhui Shi

Phys Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a Pilot External Quality Assessment Scheme for Genetic Testing of Newborns with Spinal Muscular Atrophy.
Wei Wang, Liping Wu, Yufan Hui, Yuxuan Du, Jiangtao Yang, Anhui Shi, Shihao Zhou

Clin Lab· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of lymph node recurrence patterns and delineation guidelines of radiation field in middle thoracic oesophageal carcinomas after radical surgery: a real-world study.
Rongxu Du, Songqing Fan, Dan Yang, Xiaobin Wang, Xia Hou, Anhui Shi

BMC Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced or metastatic esophageal cancer: A propensity score-matched analysis.
Wei Deng, Xiao Chang, Xin Dong, Yuting Zhao, Dan Yang, Anhui Shi

Int Immunopharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial.
Xue Meng, Anping Zheng, Jun Wang, Xiaoyuan Wu, Guang Li, Anhui Shi

Br J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemoradiotherapy followed by oesophagectomy may be the optimal treatment option for lower thoracic oesophageal cancer with supraclavicular lymph node metastasis: An inverse probability of treatment-weighted analysis of SEER database.
Xiao Chang, Jiayue Liu, Yuting Zhao, Anhui Shi, Huiming Yu

J Med Imaging Radiat Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal Dissection.
Xu Yang, Lina Zhao, Anhui Shi, Cong Chen, Jianzhong Cao

Am J Gastroenterol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial.
Jing You, Shuchai Zhu, Jiancheng Li, Jie Li, Junyue Shen, Anhui Shi

Int J Radiat Oncol Biol Phys· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line atezolizumab/durvalumab plus platinum-etoposide combined with radiotherapy in extensive-stage small-cell lung cancer.
Lijuan Li, Dan Yang, Yanmei Min, Anyan Liao, Jing Zhao, Anhui Shi

BMC Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prediction model for dosimetric-based lung adaptive radiotherapy.
Chaoqiong Ma, Zhen Tian, Ruoxi Wang, Zhongsu Feng, Fan Jiang, Anhui Shi

Med Phys· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative lymphatic recurrence distribution and delineation of the radiation field in lower thoracic squamous cell esophageal carcinomas: a real-world study.
Rongxu Du, Songqing Fan, Xiaobin Wang, Xia Hou, Cheng Zeng, Anhui Shi

Radiat Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial.
Qing Zhou, Ming Chen, Ou Jiang, Yi Pan, Desheng Hu, Anhui Shi, Jianhua Shi

Lancet Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Enteral Nutrition on Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy: A Prospective, Multicentre, Randomised, Controlled Study.
Jiahua Lyu, Anhui Shi, Tao Li, Jie Li, Ren Zhao, Hanping Shi

Front Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT.
Junyue Shen, Dan Yang, Mailin Chen, Leilei Jiang, Xin Dong, Anhui Shi

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis